Bottom line
MAPXX vs MEXX: the short answer
MAPXX (Money Market Portfolio) and MEXX (Direxion Daily MSCI Mexico Bull 3X ETF) are both money market funds.
MAPXX is cheaper at 0.2% vs 1.23% — a difference of $103 a year per $10,000 invested.
Over one year, MEXX returned +181.2% vs +4.4% for MAPXX.
Updated Nov 19, 2026
MAPXX vs MEXX side by side
| MAPXX | MEXX | |
|---|---|---|
| Type | Money market fund | Money market fund |
| Fund family | Morgan Stanley | Direxion |
| Category | Money Market | Money Market |
| Expense ratio | 0.2% | 1.23% |
| Annual cost per $10k | $20 | $123 |
| 10-yr cost on $10k (prospectus) | $290 | $1,520 |
| Max front load | — | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +4.4% | +181.2% |
| 5-yr return (annualized) | — | +16.8% |
| 10-yr return (annualized) | — | — |
| Best quarter | +1.1% | +109.3% |
| Worst quarter | +1.0% | −83.1% |
| Net assets (fund) | — | $19.8M |
| Number of holdings | — | 10 |
| Portfolio turnover | — | 75% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | MAPXX | MEXX | Difference |
|---|---|---|---|
| 2025 | +4.4% | +181.2% | −176.8% |
Source: Fund prospectus bar charts
Holdings overlap
MAPXX and MEXX share none of their top holdings.
MAPXX top 10
MEXX top 10
- Dreyfus — 46.50%
- Ishares MSCI Spain Capped Et — 44.83%
- Goldman Financial — 15.52%
- Dreyfus — 10.30%
- N/a — 7.80%
- N/a — 5.12%
- N/a — 3.77%
- Goldman Sachs Liq Es Fd A — 3.08%
- N/a — 2.57%
- N/a — 0.87%
FAQ
What is the difference between MAPXX and MEXX?
MAPXX (Money Market Portfolio) and MEXX (Direxion Daily MSCI Mexico Bull 3X ETF) are both money market funds. MAPXX is cheaper at 0.2% vs 1.23% — a difference of $103 a year per $10,000 invested.
Which is cheaper, MAPXX or MEXX?
MAPXX has the lower expense ratio (0.2%).
Should I own both MAPXX and MEXX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.